Oncology
Oncology
Advertisement
Jordana JampelCervical Cancer | January 17, 2025
Results were deduced from self-collected as well as clinician-obtained screening results.
Read More
Rob DillardBreast Cancer News | January 17, 2025
In patients with high-risk HER2-psoitive breast cancer, adjuvant trastuzumab emtansine reduces the long-term risk of death.
Rob DillardMelanoma | January 14, 2025
A recent study shows that macrophages can be used to predict whether or not a melanoma patient will respond to chemotherapy.
Jordana JampelBreast Cancer News | January 10, 2025
The study used SEER data of nearly 20,000 cases.
Rob DillardBreast Cancer News | January 8, 2025
A groundbreaking study has demonstrated that artificial intelligence can enhance breast cancer detection rates by almost 20%.
Jordana JampelBreast Cancer News | January 8, 2025
New research on active monitoring versus surgery in DCIS was presented at SABCS 2024.
Jordana JampelOvarian Cancer | January 8, 2025
A team of researchers aimed to analyze the genetic expression and prognostic value of selenoprotein gene mutations.
Rob DillardMelanoma | January 7, 2025
A recent study found a connection between total serum calcium levels and developing melanoma.
Rob DillardBreast Cancer News | January 2, 2025
People diagnosed with metastatic breast cancer have a notably increased risk of developing heart disease.
Dr. Sadie Dobrozsi, EvolentBreast Cancer News | December 19, 2024
Dr. Sadie Debrozsi discusses the importance of "pan-cancer" testing, especially as it pertains to breast cancer.
Dr. John Fruehauf, EvolentMelanoma | December 19, 2024
Dr. John Fruehauf provided an in-depth overview of treatments for metastatic melanoma.
Jordana JampelMelanoma | December 18, 2024
The primary outcomes of the study were melanoma-related deaths and nonmelanoma-related deaths.
Jordana JampelBreast Cancer News | December 18, 2024
The CDK4/6 inhibitor showed meaningful improvement in HR+, HER+ disease.
Jordana JampelHead and Neck Cancer | December 12, 2024
The researchers hypothesized that the prognostic value of diurnal cortisol aberrations will hold in HNC.
Jordana JampelBreast Cancer News | December 12, 2024
The positive predictive value for cancer was 15% higher for those enrolled.
Jordana JampelMelanoma | December 4, 2024
TPC2 and Rab7a interaction may be responsible for melanoma proliferation.
Jordana JampelBreast Cancer News | December 3, 2024
The most frequent changes detected were additional copies of chromosome 1q and losses of chromosomes 10q, 16q, and 22.
Jordana JampelGynecologic Cancer | November 26, 2024
Based on these results, a three-diode laser vaginal session enhances and favors the complete closure of VVFs.
Rob DillardMelanoma | November 21, 2024
Remote analysis of cancerous-looking skin growths yields the same level of accuracy as in-person analysis.
Jordana JampelBreast Cancer News | November 19, 2024
Twelve chemicals were associated with increased breast cancer risk.
Advertisement
Advertisement
Advertisement
Latest News

January 19, 2025